A. Norton

Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

Paul J. Ross, S. Ashley, A. Norton et al. · British Journal of Cancer · 2004 · 470 citations · Full text

A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial

E O’Brien, David Watkins, C. Ryan et al. · Annals of Oncology · 2005 · 123 citations · Full text

Oncology, Malignant Mesothelioma, Randomised Trial +5

Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma

Gary Middleton, Ian E. Smith, E O’Brien et al. · Annals of Oncology · 1998 · 90 citations

Surgical Oncology, Good Symptom Relief, Malignant Mesothelioma +7

The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma

Eleni Andreopoulou, Paul J. Ross, Mary O’Brien et al. · Annals of Oncology · 2004 · 42 citations · Full text

Oncology, Mitomycin C, Malignant Mesothelioma +6

Serum p53 antibodies: predictors of survival in small-cell lung cancer?

P. Murray, Thierry Soussi, Mary O’Brien et al. · British Journal of Cancer · 2000 · 34 citations · Full text